MC Riddle, J Rosenstock, J Gerich - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In a randomized, open-label, parallel, 24-week
multicenter trial, 756 overweight men and women with inadequate glycemic control
(HbA 1c >7.5%) on one or two oral agents continued prestudy oral agents and ... Cited by 424 - Related articles - BL Direct - All 6 versions
- ►annals.org [PDF] A Fritsche, MA Schweitzer, HU Haring… - Annals of internal medicine, 2003 - Am Coll Physicians Glimepiride Combined with Morning Insulin Glargine, Bedtime Neutral ...
Protamine Hagedorn Insulin, or Bedtime Insulin Glargine in Patients ... Andreas
Fritsche, MD; Matthias Axel Schweitzer, MD; Hans-Ulrich Häring, MD; and ... Cited by 158 - Related articles - BL Direct - All 7 versions
P Raskin, E Allen, P Hollander, A Lewin, RA … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—A total of 209 subjects completed the study. At study end, the mean
HbA 1c value was lower in the BIAsp 70/30 group than in the glargine group (6.91
± 1.17 vs. 7.41 ± 1.24%, P < 0.01). The HbA 1c reduction was greater in ... Cited by 323 - Related articles - All 7 versions
K Hermansen, M Davies, T Derezinski, G … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—At 24 weeks, A1C had decreased by 1.8 and 1.9% (from 8.6 to 6.8 and
from 8.5 to 6.6%) for detemir and NPH, respectively (NS). In both groups, 70% of
participants achieved an A1C ≤7.0%, but the proportion achieving this ... Cited by 223 - Related articles - BL Direct - All 9 versions
HU Janka, G Plewe, MC Riddle, C Kliebe- … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In a 24-week, multinational, multicenter, open,
parallel group clinical trial, 371 insulin-naïve patients with poor glycemic
control (fasting blood glucose [FBG] ≥120 mg/dl, HbA 1c 7.5–10.5%) on ... Cited by 222 - Related articles - All 8 versions
- Free from Publisher J Rosenstock, SL Schwartz, CM Clark Jr, GD … - Diabetes Care, 2001 - 万方数据资源系统 OBJECTIVE: To determine the safety and efficacy of the long-acting analog
insulin glargine compared with NPH insulin in patients with type 2 diabetes who
were previously treated with insulin alone. RESEARCH DESIGN AND METHODS: A ... Cited by 345 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org [PDF] H Yki-Jarvinen, A Dressler, M Ziemen - Diabetes Care, 2000 - Am Diabetes Assoc (3,2), sulfonylureas and metformin (1,3,5), or metformin alone (3) gives as good
overall glycemic control than the use of several insulin injections (1,3,4,6,7).
However, use of NPH insulin creates 2 problems. If NPH insulin is injected ... Cited by 155 - Related articles - All 5 versions
- Free from Publisher A Wright, AC Burden, RB Paisey, CA CULI, … - Diabetes Care, 2002 - cat.inist.fr OBJECTIVE- To evaluate the efficacy of the addition of insulin when maximal
sulfonylurea therapy is inadequate in individuals with type 2 diabetes. RESEARCH
DESIGN AND METHODS- Glycemic control, hypoglycemia, and body weight were ... Cited by 222 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org [PDF] M Lepore, S Pampanelli, C Fanelli, F Porcellati … - Diabetes, 2000 - Am Diabetes Assoc To compare the pharmacokinetics/dynamics of the long- acting insulin analog
glargine with NPH, ultralente, and continuous subcutaneous (SC) infusion of
insulin lispro (continuous subcutaneous insulin infusion [CSII]), 20 ... Cited by 514 - Related articles - BL Direct - All 7 versions
H Yki-Järvinen, R Kauppinen-Mäkelin, M … - Diabetologia, 2006 - Springer Page 1. Diabetologia (2006) 49: 442–451 DOI 10.1007/s00125-005-0132-0 ARTICLE H.
Yki-Järvinen . R. Kauppinen-Mäkelin . M. Tiikkainen . M. Vähätalo . ... Cited by 156 - Related articles - BL Direct - All 7 versions
